OptiBiotix Health (OB3) Stock Statistics & Valuation Metrics
Total Valuation
OptiBiotix Health has a market cap or net worth of EUR 6.94M. The enterprise value is EUR 5.62M.
- Market Cap
- EUR 6.94M
- Enterprise Value
- EUR 5.62M
Share Statistics
OptiBiotix Health has 103,300,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 103,300,300
- Owned by Insiders
- 0.24%
- Owned by Institutions
- ―
Financial Efficiency
OptiBiotix Health’s return on equity (ROE) is -0.62 and return on invested capital (ROIC) is -47.48%.
- Return on Equity (ROE)
- -0.62
- Return on Assets (ROA)
- -0.56
- Return on Invested Capital (ROIC)
- -47.48%
- Return on Capital Employed (ROCE)
- -0.48
- Revenue Per Employee
- 129.56K
- Profits Per Employee
- -432.22K
- Employee Count
- 9
- Asset Turnover
- 0.17
- Inventory Turnover
- 1.85
Valuation Ratios
The current PE Ratio of OptiBiotix Health is -1.35. OptiBiotix Health’s PEG ratio is 0.00.
- PE Ratio
- -1.35
- PS Ratio
- 4.49
- PB Ratio
- 1.22
- Price to FCF
- -6.94
- Price to Operating Cash Flow
- -3.38
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, OptiBiotix Health had revenue of 1.17M and earned -3.89M in profits. Earnings per share was -0.04.
- Revenue
- 1.17M
- Gross Profit
- 614.00K
- Operating Income
- -3.13M
- Pretax Income
- -3.94M
- Net Income
- -3.89M
- EBITDA
- -2.93M
- Earnings Per Share (EPS)
- -0.04
Cash Flow
In the last 12 months, operating cash flow was -1.71M and capital expenditures 875,000, giving a free cash flow of -834.00K billion.
- Operating Cash Flow
- -1.71M
- Free Cash Flow
- -834.00K
- Free Cash Flow per Share
- -0.01
Dividends & Yields
OptiBiotix Health pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -14.42%
- Earnings Yield
- -74.07%
Stock Price Statistics
- Beta
- 0.81
- 52-Week Price Change
- 4.92%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.07
- Relative Strength Index (RSI)
- 41.84
- Average Volume (3m)
- ―
Important Dates
OptiBiotix Health upcoming earnings date is Jul 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 17, 2026
- Next Earnings Date
- Jul 01, 2027
- Ex-Dividend Date
- ―
Financial Position
OptiBiotix Health as a current ratio of 4.27, with Debt / Equity ratio of 0.00%
- Current Ratio
- 4.27
- Quick Ratio
- 3.49
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.35
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, OptiBiotix Health has paid -53.00K in taxes.
- Income Tax
- -53.00K
- Effective Tax Rate
- 0.01
Enterprise Valuation
OptiBiotix Health EV to EBITDA ratio is -2.14, with an EV/FCF ratio of -5.75.
- EV to Sales
- 3.72
- EV to EBITDA
- -2.14
- EV to Free Cash Flow
- -5.75
- EV to Operating Cash Flow
- -2.81
Balance Sheet
OptiBiotix Health has EUR 989.00K in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of EUR 989.00K billion.
- Cash & Marketable Securities
- EUR 989.00K
- Total Debt
- EUR 0.00
- Net Cash
- EUR 989.00K
- Net Cash Per Share
- EUR 0.01
- Tangible Book Value Per Share
- EUR 0.04
Margins
Gross margin is 45.50%, with operating margin of -190.06%, and net profit margin of -332.69%.
- Gross Margin
- 45.50%
- Operating Margin
- -190.06%
- Pretax Margin
- -338.35%
- Net Profit Margin
- -332.69%
- EBITDA Margin
- -173.91%
- EBIT Margin
- -190.06%
Analyst Forecast
The average price target for OptiBiotix Health is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 8.23%
- EPS Growth Forecast
- -2881.25%
